PRESS RELEASE: AdvantAge Integrative Medicine to Participate in National Institutes of Health TACT2 Research Trial
Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack FOR IMMEDIATE RELEASE (Grand Junction, CO – December 2017). AdvantAge Integrative Medicine Center has been named a participating clinical site for the second Trial to Assess Chelation Therapy (TACT2). TACT2 will examine the use of […]